Evidence map›Paper›PMID 42759381›Full record

ArticleESMO open2026

Advancing cancer care for adolescents and young adults: the role of the European Network of Expertise.

A Ferrari, S Provenzano, C Prampolini, W van der Graaf, O Husson, J D Morgan, P Quarello, C Larrosa, A Castaneda Heredia, F Peccatori and 16 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ESMO open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

A FerrariPediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy.
S ProvenzanoMesenchymal and Rare Cancer Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
C PrampoliniEvaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: chiara.prampolini@istitutotumori.mi.it.
W van der GraafDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
O HussonDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
J D MorganDepartment of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
P QuarelloPediatric Onco-Hematology, Stem Cell Transplantation and Cellular Therapy Division, Regina Margherita Children's Hospital, Turin, Italy; Department of Pediatric and Public Health Sciences, University of Turin, Turin, Italy.
C LarrosaPediatric Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
A Castaneda HerediaPediatric Oncology Unit, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.
F PeccatoriGynecologic Oncology Department, European Institute of Oncology IRCCS, Milan, Italy.
D StarkInstitute of Medical Research, University of Leeds, UK and Leeds Teaching Hospitals NHS Trust, Leeds, UK.
V LaurenceAdolescents and Young Adults Unit, Medical Oncology and SIREDO (Care, Innovation and Research for Children, Adolescents, and Young Adults with Cancer) Departments, Curie Institute, Paris, France.
N GasparDépartement de Cancérologie de l'Enfant et l'Adolescent, Gustave Roussy, Villejuif, France.
H A PoirelCancer Center, Epidemiology and Public Health, Sciensano, Brussels, Belgium.
F Van AelstCancer Center, Epidemiology and Public Health, Sciensano, Brussels, Belgium.
E FranceschiAzienda USL/IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
E SaloustrosDepartment of Oncology, University Hospital of Larissa, Larissa, Greece.
U DirksenUniversity Hospital Essen, West German Cancer Center Essen, Board of Directors, Essen, North Rhine-Westphalia, Germany; Department of Pediatrics III (Oncology, Hematology, Cardiology, Rheumatology, Pulmonology), University Hospital Essen, Essen, North Rhine-Westphalia, Germany.
A KienesbergerChildhood Cancer International Europe, Vienna, Austria.
C SchneiderChildhood Cancer International Europe, Vienna, Austria.
I MurphyChildhood Cancer International Europe, Vienna, Austria.
U KosirYouth Cancer Europe, Cluj-Napoca, Romania.
K RizviYouth Cancer Europe, Cluj-Napoca, Romania.
M FiorenteSIOP Europe, The European Society for Paediatric Oncology, Brussels, Belgium.
P CasaliDepartment of Oncology and Hemato-oncology, University of Milan, Milan, Italy; Mesenchymal and Rare Cancer Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
A TramaEvaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adolescents and young adults (AYAs, aged 15-39 years at cancer diagnosis) are recognized as a distinct patient group with specific clinical and psychosocial needs requiring tailored care. This article presents the Network of Expertise (NoE) on AYAs with cancer developed through the Joint Action on Network of Expertise to strengthen AYA research and care across Europe. The NoE adopts a structured, collaborative approach aligning national and European Union-level goals, creating a platform for professionals, patient groups, and stakeholders to advance AYA cancer care, influence policy, and reduce disparities among member states. It also promotes cooperation between pediatric and adult oncology services to improve care throughout the cancer continuum. The article highlights the main challenges ahead and emphasizes that their successful resolution depends on shared commitment to collaboration-ultimately aiming to enhance outcomes and quality of life for AYAs with cancer.

Indexed as

AYAcancerEuropean Unionhealth care networkinghealth policy

Identifiers

PMID42759381
PMCPMC13625873

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.